Skip to content
Home/Companies/MedTech/Neurovalens
NE

Neurovalens

MedTech·UK·Active·6yr hold

Neurovalens is a healthcare company, headquartered in UK.

Entry
2020
Hold
6yr
Status
Active
Est. EV
–

Who owns Neurovalens?

Neurovalens is currently owned by Clarendon Fund Managers through Co-Fund NI (2012 vintage), since 2020. Across its history, Neurovalens has been through 2 private equity ownership periods, detailed in the timeline below.

Hand-verified · updated 2026-04-21

Clarendon Fund Managers
Most recent investor
Clarendon Fund Managers
Co-Fund NI · 2012 · VC
2 ownership periods · full history below

Key facts

HQUK
SectorHealthcare

Ownership history

2 ownership periods

Active
Co-held by Clarendon Fund Managers and ACF Investors since 2020.
Clarendon Fund Managers
Clarendon Fund ManagersActive
2020 · present · Co-Fund NI · 2012 · VC
MOIC
–
ACF Investors
ACF InvestorsActive
present · Angel CoFund · 2011 · VC
MOIC
–

More from Co-Fund NI

Other portfolio companies in the same fund.

B-Secur
Active
CybersecurityUK· 2020
Sonrai Analytics
Active
HealthTechUK· 2020
axial3D
Active
MedTechUK· 2019
AuditComply
Exited 2025
SoftwareUK· 2015
to

More PE-backed in MedTech

Comparable medtech deals from other GPs.

Lattice Medical
Active
Finovam GestionFrance
QTAS
Active
OVNI CapitalGermany
Serres
Active
G Square Healthcare PEFinland· 2026
Stago
Active
ARCHIMEDFrance· 2026
Amoena
Active
Apera Asset ManagementGermany· 2025
Amotio
Active
Development Bank of WalesUK· 2025
Data refreshed weekly · Sourced from public filings